On the jump forward of CRISPR genome editing beta islet cells, preempting the need for immunosuppression, for a one-shot treatment of autoimmune (Type 1) diabetes https://
nejm.org/doi/full/10.10
56/NEJMe2507578
… https://
nature.com/articles/d4158
6-025-02802-5
…
CRISPR Beta Cell Editing Eliminates Immunosuppression Need Type 1 Diabetes
By
–